Wanda Sports (WSG) SC 14D9Tender offer solicitation

 

The name of the subject company to which this Solicitation/Recommendation Statement on Schedule 14D-9 (together with any exhibits and annexes attached hereto, this “Schedule 14D-9”) relates is Wanda Sports Group Company Limited (the “Company”), a company limited by shares incorporated under the laws of Hong Kong. The Company’s principal executive office is located at 9/F, Tower B, Wanda Plaza, 93 Jianguo Road, Chaoyang District, 100022, Beijing, People’s Republic of China. The Company’s telephone number at this address is +86-10-8558-8813.

The title of the class of equity securities to which this Schedule 14D-9 relates is the Company’s class A ordinary shares, with no par value (“Class A Ordinary Shares”), and American depositary shares (“ADSs”), with every two ADSs representing three Class A Ordinary Shares. The ADSs were issued under a facility created pursuant to the Deposit Agreement, dated as of July 26, 2019 and as amended, by and among the Company, Deutsche Bank Trust Company Americas (the “Depositary”), and holders and beneficial owners of ADSs issued thereunder (the “Deposit Agreement”).

As of December 16, 2020, there were (a) 61,907,582 Class A Ordinary Shares issued and outstanding (excluding shares in (c)), including 41,855,022 Class A Ordinary Shares represented by ADSs, (b) 146,967,707 class B ordinary shares of the Company, with no par value (“Class B Ordinary Shares,” together with the Class A Ordinary Shares, the “Shares”) and (c) 328,053 Class A Ordinary Shares (all of which are represented by ADSs) reserved (but not yet allocated) for issuance, settlement and allocation upon exercise or vesting of outstanding share incentive awards to purchase Class A Ordinary Shares under the Company’s Management Equity Incentive Plan.

The filing person is the Company. The name, business address and business telephone number of the Company are set forth above in “Item 1. Subject Company Information—Name and Address.”

The name, citizenship, principal business address, principal occupation and business experience during the past five years of each of the Company’s directors and executive officers is set forth in Annex A hereto. None of the listed persons, during the past five years, has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or was a party to any judicial or administrative proceeding (except for matters that were dismissed without sanction or settlement) that resulted in a judgment, decree, or final order enjoining him from future violations of, or prohibiting activities subject to, federal or state securities laws or finding any violations of federal or state securities laws. Unless otherwise indicated, all directors and executive officers of the Company are citizens of the People’s Republic of China. The business address of the directors and executive officers is 9/F, Tower B, Wanda Plaza, 93 Jianguo Road, Chaoyang District, 100022, Beijing, People’s Republic of China.

(d) Tender Offer and the Transaction.

This Schedule 14D-9 relates to the cash tender offer (the “Offer”) by Wanda Sports & Media (Hong Kong) Holding Co. Ltd. (“Purchaser”), a limited liability company incorporated under the laws of Hong Kong SAR, People’s Republic of China and a wholly-owned subsidiary of Wanda Culture Holding Co., Ltd., a limited liability company incorporated under the laws of Hong Kong SAR, People’s Republic of China (“Parent”), to acquire all of the outstanding Class A Ordinary Shares (including Class A Ordinary Shares represented by ADSs) at an offer price of $1.70 per Class A Ordinary Share or $2.55 per ADS in cash (the “Offer Price”), without interest, upon terms, and

subject to conditions, set forth in the Offer to Purchase and Letters of Transmittal (each as defined below). Parent is indirectly owned by Dalian Wanda Group Co., Ltd, which is ultimately controlled by Mr. Jianlin Wang, its chairman and president. As of the date hereof, Purchaser directly and indirectly holds (i) one Class A Ordinary Share and (ii) 146,967,707 Class B Ordinary Shares, which are all of the currently issued and outstanding Class B Ordinary Shares of the Company, representing approximately 70.4% of all the outstanding Shares and 90.5% of the total voting power represented by all outstanding Shares.

The Offer is disclosed in the Tender Offer Statement on Schedule TO (“Schedule TO”) filed by Purchaser and Parent with the U.S. Securities and Exchange Commission (the “SEC”) on December 23, 2020, and is made upon the terms and subject to the conditions set forth in the Offer to Purchase (as it may be amended or supplemented from time to time, the “Offer to Purchase”) and in the related letter of transmittal for Class A Ordinary Shares (the “Share Letter of Transmittal”) and the related letter of transmittal for ADSs (the “ADS Letter of Transmittal,” together with the Share Letter of Transmittal, “Letters of Transmittal”). The Offer to Purchase and forms of Letters of Transmittal are being mailed with this Schedule 14D-9 and are filed as Exhibits (a)(1)(A), (a)(1)(B) and (a)(1)(C) to this Schedule 14D-9, respectively, and are incorporated herein by reference.

The obligation of Purchaser to purchase Class A Ordinary Shares (including Class A Ordinary Shares represented by ADSs) tendered in the Offer is subject to the conditions that (a) no law, statute, rule or regulation shall have been enacted or promulgated by any governmental entity of competent jurisdiction (in a jurisdiction material to the business of the Company or Purchaser) which prohibits or makes illegal the consummation of the Offer, Second Step Option or the Deposit Agreement Termination/Delisting (each as defined below); and (b) no order or injunction of a court or governmental entity of competent jurisdiction (in a jurisdiction material to the business of the Company or Purchaser) shall have been in effect preventing the consummation of the Offer , Second Step Option or the Deposit Agreement Termination/Delisting in any material respect (collectively, the “Offer Conditions”). Subject to the satisfaction or waiver by Purchaser of the Offer Conditions, Purchaser will accept for payment, promptly after the expiration date of the Offer, all Class A Ordinary Shares (including Class A Ordinary Shares represented by ADSs) tendered (and not validly withdrawn) under the Offer and pay for such Shares.

Purchaser commenced (within the meaning of Rule 14d-2 promulgated under the Securities Exchange Act of 1934, as amended, the “Exchange Act”) the Offer on December 23, 2020. Subject to the terms and conditions of the Offer, the Offer will initially be scheduled to expire at 5:00 PM, New York City Time, on January 29, 2021, the date that is 24 business days (for this purpose calculated in accordance with Rules 14d-1(g)(3) and 14d-2 promulgated under the Exchange Act) following commencement of the Offer.

Purchaser has reserved the right to initiate, immediately after the expiration of the Offer and acceptance of tendered Class A Ordinary Shares and ADSs, a subsequent offering period in accordance with Rule 14d-11 under the Exchange Act (the “Subsequent Offering Period”). During the Subsequent Offering Period, Purchaser will immediately accept and promptly pay for all validly tendered ADSs in the amount of US$2.55 per ADS and Class A Ordinary Shares in the amount of US$1.70 per Class A Ordinary Share.

The foregoing summary of the Offer is qualified in its entirety by the description contained in the Offer to Purchase and the Letters of Transmittal.

According to the Offer to Purchase, (i) the address of the principal executive office of Parent is Unit 606, 6th Floor, Alliance Building, 133 Connaught Road Central, Hong Kong, and the telephone number at such principal office is +86-10-8558-7385; and (ii) the address of the principal executive office of Purchaser is Room 1903, 19/F, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong, and the telephone number at such principal officer is +86-10-8558-7385.

The information relating to the Offer, including the Offer to Purchase, the Letters of Transmittal and related documents and this Schedule 14D-9, can be obtained without charge from the SEC’s website at www.sec.gov. This Schedule 14D-9 is also located on the SEC filings page of the Company’s Investor Relations website, and the Offer to Purchase and the other related materials are available directly from MacKenzie Partners, Inc., the information agent for the Offer, at toll free (800) 322-2885 or (212) 929-5500.

In connection with the commencement of the Offer, the Company has agreed to terminate the Deposit Agreement (the “Deposit Agreement Termination”), for which the Depositary will distribute a notice on December 23, 2020 notifying ADS holders of the Deposit Agreement Termination, to be effective upon January 29, 2021 (the “Deposit Agreement Termination Date”). Following the Deposit Agreement Termination Date and through March 1, 2020 (the “ADS Transitional Period”), each ADS holder will continue to be entitled, subject to the terms and conditions of the Deposit Agreement and any Depositary Sale (as defined below), to surrender ADSs and withdraw Class A Ordinary Shares upon payment by the holder of a cancellation fee of $0.05 per ADS payable to the Depositary and Hong Kong stamp duty of 0.2% of the value of the underlying Class A Ordinary Shares (a “Surrender/Withdrawal”), however, the Depositary will no longer provide any other service in respect of the ADSs, including registration of any transfers of ADSs between holders of ADSs. Other than through a Surrender/Withdrawal, an ADS holder will not receive any underlying Class A Ordinary Shares. Following the expiration of the ADS Transitional Period, an ADS holder will still be able to effect a Surrender/Withdrawal to the extent the Depositary has not sold all Class A Ordinary Shares represented by ADSs in a Depositary Sale; to the extent that any Class A Ordinary Shares have been sold in Depositary Sales, a Surrender/Withdrawal will result in the distribution of Class A Ordinary Shares and a pro rata distribution of cash proceeds (as described below) of such Depositary Sales. In addition, the Company will have undertaken the delisting of the ADSs from the Nasdaq Global Select Market (“Nasdaq”) by filing a Form 25 with the SEC (the “Delisting,” and together with the Deposit Agreement Termination, the “Deposit Agreement Termination/Delisting”), as a result of which there will no longer be a public market for the ADSs. The Delisting is expected to be effective upon, or shortly after, the Deposit Agreement Termination Date. As a result of the Deposit Agreement Termination/Delisting, which will precede any other Second Step Options (as defined below), the ADSs will no longer be tradeable and there will be no listing of any securities of the Company on any stock exchange in the United States or elsewhere.

For the purpose of this Schedule 14D-9, the Offer and any transactions undertaken in the Second Step Options (as applicable) are collectively referred to as the “Going Private Transactions.”

If a holder of Class A Ordinary Shares or ADSs does not tender his/her/its Class A Ordinary Shares or ADSs in the Offer, and continues after expiration of the Offer to hold Class A Ordinary Shares (including following a Surrender/Withdrawal), then if Purchaser does not undertake a Share Consolidation or, if it does and based on the share consolidation ratio, such holder retains some Class A Ordinary Share(s), such holder will remain a shareholder of the Company. However, there will be no public market for the then outstanding Class A Ordinary Shares after the Delisting, and the remaining shareholders will have limited rights to the Company’s information after the SEC Deregistration. In addition, after the Delisting, the Company will no longer be required to follow mandatory corporate governance standards promulgated by the listing rules of the Nasdaq.

Except as set forth in this Schedule 14D-9 or as otherwise incorporated herein by reference, as of the date hereof, to the knowledge of the Company, there are no material agreements, arrangements or understandings or any actual or potential conflicts of interest between the Company or any of its affiliates, on the one hand, and (1) Parent, Purchaser or their respective executive officers, directors or affiliates, or (2) the Company’s executive officers, directors or affiliates, on the other hand.

On September 30, 2020, Purchaser delivered to the Board a preliminary non-binding proposal (the “Proposal”) announcing its intent to acquire all of the outstanding Class A Ordinary Shares, including Class A Ordinary Shares represented by ADSs, for a purchase price of US$1.67 per Class A Ordinary Share, or US$2.50 per ADS, in cash (the “Proposed Transaction”). The Board formed an independent board committee (the “Independent Board Committee”) comprised of Messrs. Edwin Fung and Kenneth Howard Jarrett, each of whom is an independent and disinterested director of the Company, to act on behalf of the Company to consider the Proposal by Parent.

The information set forth in (i) the sections of the Offer to Purchase that are titled “The Offer — Section 8. Certain Information Concerning Purchaser” and “Schedule B — Security Ownership of Certain Beneficial Owners and Management” and (ii) the sections in the Company’s annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC on May 22, 2020 (the “Form 20-F”) that are titled “Item 6.A. Directors and Senior Management,” “Item 6.B. Compensation,” “Item 6.C. Board Practices” and “Item 7.B. Related Party Transactions” are incorporated herein by reference.

The Independent Board Committee and the Board were aware of the contracts, agreements, arrangements or understandings and any actual or potential conflicts of interest described below in this Item 3 and considered them along with other matters described below in “Item 4. The Solicitation or Recommendation—Reasons for the Offer and the Going Private Transactions; Recommendation of the Independent Board Committee; Recommendation of the Board; Fairness of the Offer and the Going Private Transactions”.

 

According to the Schedule TO, other than as set forth in the Offer to Purchase or Schedule B to the Offer to Purchase, no transactions in the Shares have been effected during the past 60 days by Parent, Purchaser or, to the best of their knowledge, any associate or controlled subsidiary of Parent, Purchaser, the Company or any person listed in Schedule A to the Offer to Purchase. See also “Arrangements with the Company’s Directors and Executive Officers”.

In considering the recommendation of the Independent Board Committee and the Board set forth in “Recommendations of the Independent Board Committee and the Board of Directors” in Item 4, you should be aware that aside from their interests as shareholders (as applicable), the directors and executive officers of the Company may be considered to have interests in the Going Private Transactions that are different from, or in addition to, those of other shareholders generally.

The Independent Board Committee and the Board were aware of and have considered these interests, among other matters, in evaluating the Going Private Transactions, and in recommending that all of the holders of Class A Ordinary Shares and ADSs other than Purchaser, the Associates, and their respective affiliates ( the “Unaffiliated Security Holders”) accept the Offer and tender their Class A Ordinary Shares and/or ADSs in the Offer. The following is a discussion of all known material agreements, understandings and any actual or potential conflicts of interest between the Company and its executive officers or directors that relate to the Going Private Transactions. The Company’s shareholders should take these interests into account in deciding whether to tender their Class A Ordinary Shares and/or ADSs in the Offer.

The Company’s directors and executive officers are as follows:

If the executive officers and directors of the Company tender their Class A Ordinary Shares and/or ADSs for purchase pursuant to the Offer or their Shares, they will receive the same cash consideration on the same terms and conditions as the other shareholders of the Company.

After reasonable inquiry, the Company has not been notified by any executive officer, director, affiliate or subsidiary of the Company of his/its respective plan as to whether to tender any Class A Ordinary Shares/ADSs held of record or beneficially owned by such person or entity in the Offer.

The Independent Board Committee consists of two independent members of the Board, Messrs. Edwin Fung and  Kenneth Howard Jarrett. On November 16, 2020, the Board unanimously adopted written resolutions providing that each member of the Independent Board Committee would receive a monthly compensation of $15,000 in exchange for his service on the Independent Board Committee. Such payment is not contingent upon the commencement or completion of the Offer or any alternative transactions (as defined below), or the Independent Board Committee’s recommendation of the Going Private Transactions or any alternative transactions.

In recommending and approving the compensation structure, the Board considered, among other things, other compensation structures for independent board committees/special committees of board of directors of other companies formed for purposes comparable to those for which the Independent Board Committee was formed. The Board considered the nature and scope of the Proposed Transaction and the time expected to be required by the Independent Board Committee members and determined that the compensation structure was consistent with comparable transactions that it had reviewed with its counsel.

The Independent Board Committee reviewed the terms and conditions of the Going Private Transactions, especially the terms of the Offer, with the assistance of its legal and financial advisors, and unanimously (a) determined that the Going Private Transactions are in the best interests of the Company and its shareholders, and are fair to the Unaffiliated Security Holders; and (b) recommended that the Unaffiliated Security Holders accept the Offer and tender their Class A Ordinary Shares and/or ADSs to Purchaser pursuant to the Offer.

In reaching the conclusions and in making the recommendation described above, the Independent Board Committee and the Board took into account a number of reasons described under “Reasons for the Offer and the Going Private Transactions; Recommendation of the Independent Board Committee; Recommendation of the Board; Fairness of the Offer and the Going Private Transactions” below.

The Board and senior management of the Company have been reviewing periodically the Company’s long-term strategic plan with the goal of maximizing shareholder value. As part of this ongoing process, the Board and senior management of the Company also have periodically reviewed strategic alternatives that may be available to the Company.

On September 30, 2020, Purchaser delivered to the Board the Proposal announcing its intent to acquire all of the outstanding Class A Ordinary Shares, including Class A Ordinary Shares represented by ADSs, for a purchase price of US$1.67 per Class A Ordinary Share, or US$2.50 per ADS, in cash. In connection with finalizing the Proposal and preparing for the Proposed Transaction, Purchaser retained Deutsche Bank AG, Hong Kong Branch (“Deutsche Bank”) as its financial advisor and Paul, Weiss, Rifkind, Wharton & Garrison LLP (“Paul Weiss”) as its legal counsel.

During the ensuing days, the Independent Board Committee considered the proposals of several investment banks and legal counsels, including their experience with similar transactions, reputation, knowledge of the relevant industry, fee proposals, and relevant qualifications of team members and potential conflicts of interests. After careful consideration, the Independent Board Committee decided to engage Houlihan Lokey (China) Limited (“Houlihan Lokey”) as its financial advisor and Skadden, Arps, Slate, Meagher & Flom LLP (“Skadden”) as its legal counsel to assist the Independent Board Committee in evaluating and the negotiating the Proposed Transaction. Among the reasons for Houlihan Lokey’s and Skadden’s selection were their respective extensive experiences in similar transactions, strong reputation, significant experience dealing with China-based companies, and lack of existing material relationships with the Company or Purchaser. The Independent Board Committee, on behalf of the Company, retained Skadden on October 22, 2020 and Houlihan Lokey on October 23, 2020, respectively. On October 23, 2020, the Company issued a press release regarding the Independent Board Committee’s appointment of Houlihan Lokey as its financial advisor and Skadden as its legal counsel. On the same date, the Company furnished to the SEC its press release as an exhibit to a current report on Form 6-K.

 

On October 26, 2020, the Independent Board Committee convened an organizational meeting by telephone with Skadden and Houlihan Lokey. During the meeting, representatives of Skadden led the Independent Board Committee in a discussion of its key duties and responsibilities in the context of the Proposed Transaction, and Houlihan Lokey led the Independent Board Committee in a discussion regarding its financial due diligence requirement and work plan. Thereafter, the Independent Board Committee discussed with its advisors, among other things, certain shareholder inquiry letter that they had received regarding the Proposed Transaction and instructed Houlihan Lokey to review the inquiry letter and take into consideration any reasonable suggestions from the shareholder when conducting its financial analysis on the Company. Following such discussion, the Independent Board Committee invited representatives of Paul Weiss to join the meeting on behalf of Purchaser to provide clarification on certain key commercial and legal terms of the Proposed Transaction contemplated by Purchaser. Representatives of Paul Weiss shared with the Independent Board Committee and its advisors certain backgrounds and preliminary thoughts of Purchaser with respect to the structure and key terms of the Proposed Transaction, including that (i) Purchaser proposed to make a tender offer to facilitate the Delisting and SEC Deregistration; (ii) Purchaser proposed to have the acceptance of tendered Class A Ordinary Shares and ADSs conditioned upon the satisfaction of 90% Threshold and certain other conditions customary to similar transactions; and (iii) Purchaser did not intend to have any financing condition to the Offer. The Independent Board Committee then requested its advisors to engage in discussion with Purchaser to better understand the various steps in connection with Purchaser’s proposal.

From October 26, 2020 to November 16, 2020, the Independent Board Committee had several discussions with representatives of Skadden and the Company to lay out in more details, and to reinforce, the authority of the Independent Board Committee in relation to its review and evaluation of the Proposed Transaction. The Board adopted resolutions in a meeting held on November 16, 2020 to grant the Independent Board Committee all such power and authority as may be necessary or advisable to permit the Independent Board Committee to effectively exercise the Original Committee Authorities and discharge its duty in relation thereto, including without limitation the power and authority, at the Company’s expenses, to: (i) participate in the negotiation on the Company’s behalf of proposed terms of the Proposed Transaction or any alternative transaction to the Proposal, either separately or as part of the Proposal (each such alternative transaction, an “Alternative Transaction”); (ii) advise and make a recommendation to the Unaffiliated Security Holders with respect to the Proposed Transaction or any Alternative Transaction; (iii) review, evaluate and negotiate the terms and conditions of the Proposed Transaction or Alternative Transaction and to respond to any communications, inquiries, or proposals regarding the Proposal or any Alternative Transaction; (iv) be given full access to all such books, records and other information and documents of, or in the possession of the Company, or available to the Company to assist it in its evaluation of the Proposal or any Alternative Transaction; and (v) explore, investigate, and consider any Alternative Transaction and matters related thereto as the Independent Board Committee deems appropriate (together with the Original Committee Authorities, collectively “Committee Authorities”).

 

Starting from October 26, 2020 through December 4, 2020, as directed by the Independent Board Committee, representatives of Houlihan Lokey had several discussions with members of the management of the Company and Infront in connection with Houlihan Lokey’s financial due diligence on the Company, including, among others, receiving from, and discussing with, the management of the Company certain financial projections prepared by the management of the Company in relation to the Proposed Transaction (the “Financial Projections”).

From October 27, 2020 to November 12, 2020, representatives of Skadden and Paul Weiss had a number of discussions on the key legal and commercial terms of the Proposed Transaction contemplated by Purchaser, including, among other things, different approaches to complete the Proposed Transaction (including the Second Step Options), the terms and conditions of the Offer, and the source of funding of Purchaser. On behalf of Purchaser, Paul Weiss noted that the Offer would be made by Purchaser on the basis that the Company would approve the Deposit Agreement Termination/Delisting before or at the same time when the Offer is commenced. Paul Weiss also noted that Purchaser was not interested in selling any of the Class B Ordinary Shares of the Company it owned. After such discussion, representatives of Skadden reported to the Independent Board Committee during a teleconference meeting held on November 13, 2020 more details on the proposed structure of the Proposed Transaction contemplated by Purchaser, including the transactions contemplated in the Second Step Options.

From October 21, 2020 to November 16, 2020, the Company and representatives of the Depositary discussed the possibility of revising the termination procedure of the Deposit Agreement. Following such discussions, the Company and the Depositary agreed to enter into an amendment to the Deposit Agreement then in effect (the “Amendment to the Deposit Agreement”) to (i) shorten the notice period necessary to terminate the Deposit Agreement to 30 days; and (ii) shorten the period after which the Depositary may sell any Class A Ordinary Shares then held by it following the Deposit Agreement Termination to 30 days. The Amendment to the Deposit Agreement would help streamline the time periods required by the Deposit Agreement Termination and the Depositary Sale, if necessary.

On November 16, 2020, the Board held a teleconference meeting to (i) discuss and adopt resolutions to approve and authorize the execution of the Amendment to the Deposit Agreement; and (ii) hear the presentation made by the management of the Company in connection with the rationale of the Delisting. During the meeting, the Board unanimously approved the Amendment to the Deposit Agreement.

On November 23 and November 26, 2020, the Independent Board Committee held teleconference meetings to discuss, among other things, the financial analysis model and valuation methods Houlihan Lokey proposed to adopt and apply for its financial analysis, as well as Houlihan Lokey’s preliminary feedback of its financial due diligence work on the Company. The Independent Board Committee discussed extensively with representatives of Houlihan Lokey and exchanged views on various aspects of the Financial Projections as well as on issues relating to Houlihan Lokey’s financial analysis and fairness evaluation.

On November 30, 2020, the Independent Board Committee held a teleconference meeting with the management of the Company to discuss the Financial Projections, and the reasons and assumptions the management of the Company had considered in making the Financial Projections. After discussion, the Independent Board Committee approved the Financial Projections for use by Houlihan Lokey to conduct its financial analysis.

On December 4, 2020, the Independent Board Committee held a teleconference meeting with Houlihan Lokey and Skadden to hear and discuss the presentation made by Houlihan Lokey on its preliminary financial analysis. The Independent Board Committee discussed in detail with Houlihan Lokey the valuation methods adopted by Houlihan Lokey as well as the factors Houlihan Lokey considered in adopting such methods. Houlihan Lokey advised the Independent Board Committee of the ranges of the prices that Houlihan Lokey believed can fairly present the value of the Company under different valuation methods. The Independent Board Committee noted that the offer price proposed by Purchaser fell within the valuation ranges in the preliminary financial analysis conducted by Houlihan Lokey, but believed that they should still try to seek an improvement to the offer price from Purchaser so as to obtain

the highest price reasonably available to the Unaffiliated Security Holders and instructed Houlihan Lokey to notify Deutsche Bank of the request.

Between December 4, 2020 and December 11, 2020, representatives of Skadden and Paul Weiss discussed certain terms and conditions of the Offer, and it was subsequently agreed that (i) the Offer would not be conditioned upon the 90% Threshold having been met, and (ii) Purchaser will reserve the right to keep open the Subsequent Offering Period following the acceptance of the ADSs and Class A Ordinary Shares tendered during the Offer, if the 90% Threshold is not met. Representatives of Houlihan Lokey and Skadden timely reported to, and discussed extensively with, the Independent Board Committee the developments on the Offer terms and conditions as agreed by Purchaser. During the discussions, the Independent Board Committee also noted that, given Purchaser controls over 90% voting power in the Company and does not intend to sell Class B Ordinary Shares it holds, reaching out to third parties to assess such third parties’ potential interest in an alternative transaction would be highly unlikely to produce a competing offer. Concurrently, representatives of Houlihan Lokey and Deutsche Bank discussed the Independent Board Committee’s request for the potential improvement to the offer price, and exchanged views on the factors considered and assumptions made during their respective financial analysis process, including, among others, the uncertainty for the Company to prolong its media rights contracts with Lega Serie A and the potential impact of losing Lega Serie A business on the Company’s results of operations.

On December 11, 2020, Purchaser, through Paul Weiss and Deutsche Bank, offered an improved offer price of US$2.55 per ADS, and informed the Independent Board Committee that the improved offer price shall constitute the “best and final offer” from Purchaser.

Between December 11, 2020 and December 18, 2020, representatives of Skadden and Paul Weiss continued to negotiate and finalize the terms and conditions of the Going Private Transactions. Paul Weiss also provided the Independent Board Committee proof of its available funds sufficient to complete the Going Private Transactions.

On December 22, 2020, the Independent Board Committee held a telephonic meeting with representatives of Skadden and Houlihan Lokey. Skadden reviewed the fiduciary duties applicable to the Independent Board Committee in connection with the Going Private Transaction and the key terms of the Going Private Transactions. Houlihan Lokey then presented its financial analysis to the Independent Board Committee and verbally rendered its opinion to the Independent Board Committee (which was subsequently confirmed in writing by delivery of Houlihan Lokey’s written opinion addressed to the Independent Board Committee on the same date), as to the fairness, from a financial point of view, of the Offer Price to be received by the Unaffiliated Security Holders pursuant to the terms and on the conditions set forth in the Offer to Purchase, as of the date of such opinion, based upon and subject to the procedures followed, assumptions made, qualifications and limitations on the review undertaken, and other matters considered by Houlihan Lokey in preparing its opinion. Please see “Opinion of the Independent Board Committee’s Financial Advisor” beginning on page 17 for additional information regarding the financial analysis performed by Houlihan Lokey and the opinion rendered by Houlihan Lokey to the Independent Board Committee. After considering the presentations of Skadden and Houlihan Lokey, including Houlihan Lokey’s fairness opinion, and taking into account the other factors described below under the heading titled “Reasons for the Offer and the Going Private Transactions; Recommendation of the Independent Board Committee” in this Item 4, the Independent Board Committee then unanimously (a) determined that the Going Private Transactions are in the best interests of the Company and its shareholders, and are fair to the Unaffiliated Security Holders; and (b) recommended that the Board (x) recommend that Unaffiliated Security Holders accept the Tender Offer and tender their Class A Ordinary Shares and/or ADSs to Purchaser pursuant to the terms and subject to the conditions contemplated under the Offer to Purchase and related Letters of Transmittal, and (y) approve and authorize the preparation, execution and filing with the SEC of, and the collaboration with Purchaser in the preparation and filing of, all reports, schedules, statements, documents and information concerning the Offer required to be filed by the Company and Purchaser pursuant to the Securities Act of 1933 (as amended) and Securities Exchange Act of 1934 (as amended), and rules and regulations promulgated thereunder.

Following the meeting of the Independent Board Committee, the Board convened a meeting. The Independent Board Committee provided to the Board an overview of the Going Private Transactions and presented its recommendation to the Board. After considering the proposed terms of Going Private the Transactions and the recommendation of the Independent Board Committee, the Board (i) determined the Going Private Transactions are in the best interests of the Company and its shareholders, and are fair to the Unaffiliated Security Holders; (ii) approved and adopted (x) the Deposit Agreement Termination, and (y) the Delisting; (iii) recommended that Unaffiliated Security Holders accept

the Tender Offer and tender their Class A Ordinary Shares and/or ADSs to Purchaser pursuant to the terms and subject to the conditions contemplated under Offer to Purchase and related Letters of Transmittal; and (iv) approved and authorized the preparation, execution and filing with the SEC of, and the collaboration with Purchaser in the preparation and filing of, all reports, schedules, statements, documents and information concerning the Offer and the Deposit Agreement Termination/Delisting required to be filed by the Company and Purchaser pursuant to the Securities Act of 1933 (as amended) and Securities Exchange Act of 1934 (as amended), and rules and regulations promulgated thereunder. See “Recommendation of the Board” beginning on page 16 for a full description of the resolutions of the Board at this meeting.

 

On December 23, 2020, Purchaser commenced the Offer.

The Independent Board Committee, acting with the advice and assistance of its legal and financial advisors, evaluated and negotiated the Going Private Transactions, including the terms and conditions of the Offer, and unanimously (a) determined that the Going Private Transactions are in the best interests of the Company and its shareholders, and fair to Unaffiliated Security Holders; (b) recommended that the Unaffiliated Security Holders accept the Offer and tender their Class A Ordinary Shares and/or ADSs to Purchaser pursuant to the Offer, in each case, on the terms and subject to the conditions set forth in the Offer to Purchase and related Letters of Transmittal. The Independent Board Committee also unanimously recommended to the Board to recommend the Unaffiliated Security Holders accept the Offer and tender their Class A Ordinary Shares and/or ADSs to Purchaser pursuant to the Offer.

The Independent Board Committee held multiple meetings to discuss, among other things, Purchaser’s proposal regarding the Going Private Transactions (as it was revised from time to time), especially the Offer. In the course of reaching its determination and making its recommendations, the Independent Board Committee considered, in consultation with its financial and legal advisors, information with respect to the Company’s financial condition, results of operations, businesses, competitive position and business strategy, on a historical and prospective basis, as well as current industry, and economic and market conditions and trends.

The Independent Board Committee considered the following factors as being generally supportive of its determination and recommendations:

The Independent Board Committee also considered a number of factors discussed below, relating to the procedural safeguards that it believes were and are present to ensure the fairness of the Going Private Transactions. The Independent Board Committee believes these factors support its determinations and recommendations and provide assurance of the procedural fairness of the Going Private Transactions:

In the course of reaching its determinations and making its recommendations, the Independent Board Committee also considered the following countervailing factors concerning the Going Private Transactions:

The above discussion of the information and factors considered by the Independent Board Committee is not intended to be exhaustive, but indicates the material matters considered. In reaching its determination and recommendation, the Independent Board Committee did not quantify, rank or assign any relative or specific weight to any of the foregoing factors, and individual members of the Independent Board Committee may have considered various factors differently. The Independent Board Committee did not undertake to make any specific determination as to whether any specific factor, or any particular aspect of any factor, supported or did not support its ultimate recommendation. The Independent Board Committee based its unanimous recommendation on the totality of the information presented.

The Independent Board Committee believed that the financial analyses presented by Houlihan Lokey, as more fully summarized below under the caption “Opinion of the Independent Board Committee’s Financial Advisor,” represented potential valuations of the Company. The Independent Board Committee considered each of the analyses performed by Houlihan Lokey in the context of the fairness opinion provided by Houlihan Lokey as well as various additional factors, as discussed above.

As of December 22, 2020, the Board consisted of seven directors. On December 22, 2020, the Board, in reliance on the unanimous recommendations of the Independent Board Committee and by unanimous vote, on behalf of the Company:

The Board’s approval of the Going Private Transactions included the approval of both independent directors of the Independent Board Committee and the Board. In reaching its determination, the Board considered a number of factors, including the following material factors:

The above discussion of the information and factors considered by the Board is not intended to be exhaustive, but indicates the material matters considered. In reaching its determination and recommendation, the Board did not quantify, rank or assign any relative or specific weight to any of the foregoing factors, and individual members of the Board may have considered various factors differently. The Board did not undertake to make any specific determination as to whether any specific factor, or any particular aspect of any factor, supported or did not support its ultimate recommendation. The Board based its unanimous recommendation on the totality of the information presented.

 

The Independent Board Committee retained Houlihan Lokey to act as its financial advisor in connection with the Going Private Transactions. On December 22, 2020, Houlihan Lokey verbally rendered its opinion to the Independent Board Committee (which was subsequently confirmed in writing by delivery of Houlihan Lokey’s written opinion addressed to the Independent Board Committee on the same date), as to the fairness, from a financial point of view, of the consideration of $1.70 per Share or $2.55 per ADS to be received by the Unaffiliated Security Holders in the Going Private Transactions, as of the date of such opinion, based upon and subject to the procedures followed, assumptions made, qualifications and limitations on the review undertaken, and other matters considered by Houlihan Lokey in preparing its opinion.

 

 

In arriving at its opinion, Houlihan Lokey, among other things:

 

In giving its opinion, Houlihan Lokey relied upon and assumed, without independent verification, the accuracy and completeness of all data, material and other information furnished, or otherwise made available, to Houlihan Lokey, discussed with or reviewed by Houlihan Lokey, or publicly available, and did not assume any responsibility with respect to such data, material and other information. In addition, management of the Company advised Houlihan Lokey, and Houlihan Lokey assumed, that the Management Projections (and adjustments thereto) reviewed by Houlihan Lokey were reasonably prepared in good faith on bases reflecting the best currently available estimates and judgments of such management as to the future financial results and condition of the Company and the other matters covered thereby, and Houlihan Lokey expressed no opinion with respect to such projections or the assumptions on which they were based. With respect to the publicly available research analyst estimates for the Company referred to above, Houlihan Lokey reviewed and discussed such estimates with the management of the Company and such management advised Houlihan Lokey, and Houlihan Lokey assumed, that such estimates represent reasonable estimates and judgments of the future financial results and condition of the Company and the other matters covered thereby, and Houlihan Lokey expressed no opinion with respect to such estimates or the assumptions on which they were based. Houlihan Lokey relied upon and assumed, without independent verification, that there has been no change in the businesses, assets, liabilities, financial condition, results of operations, cash flows or prospects of the Company since the respective dates of the most recent financial statements and other information, financial or otherwise, provided to Houlihan Lokey that would be material to its analyses or its opinion, and that there was no information or any facts that would make any of the information reviewed by Houlihan Lokey incomplete or misleading. The credit, financial and stock markets have recently been experiencing unusual volatility and Houlihan Lokey expressed no opinion or view as to any potential effects of such volatility on the Going Private Transaction and Houlihan Lokey’s opinion did not purport to address potential developments in any such markets.  In addition, Houlihan Lokey expressed no view as to, and Houlihan Lokey’s opinion did not address, foreign currency exchange risks (if any) associated with the Going Private Transaction, the Management Projections or otherwise.

Houlihan Lokey relied upon and assumed, without independent verification, that (a) the statements in the Offer to Purchase and all other related documents and instruments that are referred to therein are true and correct, (b) Parent, Purchaser and each party to such other related documents and instruments will fully and timely perform all of the covenants and agreements required to be performed by such party, (c) all conditions to the consummation of the Going Private Transactions will be satisfied without waiver thereof, and (d) the Going Private Transactions will be consummated in a timely manner in accordance with the terms described in the Offer to Purchase and such other related documents and instruments, without any amendments or modifications thereto. We have relied upon and assumed, without independent verification, that (i) the Going Private Transactions will be consummated in a manner that complies in all respects with all applicable foreign, federal and state statutes, rules and regulations, and (ii) all governmental, regulatory, and other consents and approvals necessary for the consummation of the Going Private Transactions will be obtained and that no delay, limitations, restrictions or conditions will be imposed or amendments, modifications or waivers made that would result in the disposition of any assets of the Company or Purchaser, or otherwise have an effect on the Going Private Transactions, or the Company that would be material to Houlihan Lokey’s analyses or its opinion. In addition, Houlihan Lokey relied upon and assumed, without independent verification, that the final Offer to Purchase as filed with the SEC will not differ in any material respect from, the draft of the Offer to Purchase identified above.

 

Furthermore, in connection with such opinion, Houlihan Lokey had not been requested to make, have had not made any physical inspection or independent appraisal or evaluation of any of the assets, properties or liabilities (fixed, contingent, derivative, off-balance-sheet or otherwise) of the Company, or any other party, nor was Houlihan Lokey provided with any such appraisal or evaluation. Houlihan Lokey had undertaken no independent analysis of any potential or actual litigation, regulatory action, possible unasserted claims or other contingent liabilities, to which the Company was or may be a party or was or may be subject, or of any governmental investigation of any possible unasserted claims or other contingent liabilities to which the Company was or may be a party or is or may be subject.

 

Houlihan Lokey was not requested to, and did not, (a) initiate or participate in any discussions or negotiations with, or solicit any indications of interest from, third parties with respect to the Going Private Transactions, the securities, assets, business or operations of the Company or any other party, or any alternatives to the Going Private Transactions, or (b) advise the Independent Board Committee, the Board, the Company or any other party with respect to alternatives to the Going Private Transactions. Houlihan Lokey’s opinion was necessarily based on financial, economic, market and other conditions as in effect on, and the information made available to Houlihan Lokey as of, the date of such opinion. Houlihan Lokey did not undertake, and is under no obligation, to update, revise, reaffirm or withdraw its opinion, or otherwise comment on or consider events occurring or coming to its attention after the date of such opinion.

 

Houlihan Lokey’s opinion was furnished for the use of the Independent Board Committee (in its capacity as such) in connection with the Independent Board Committee’s evaluation of the Going Private Transactions, and may not be used for any other purpose without Houlihan Lokey’s prior written consent. Houlihan Lokey’s opinion was not intended to be, and did not constitute, a recommendation to the Independent Board Committee, the Board, any security holder or any other party as to how to act or vote or make any election with respect to any matter relating to, or whether to tender shares in connection with, the Going Private Transactions or otherwise.

 

Houlihan Lokey was not requested to opine as to, and its opinion did not express an opinion as to or otherwise address, among other things: (i) the underlying business decision of the Independent Board Committee, the Board, the Company, or Purchaser, Parent, their respective security holders or any other party to proceed with or effect the Going Private Transactions, (ii) the terms of any arrangements, understandings, agreements or documents related to, or the form, structure or any other portion or aspect of, the Going Private Transactions or otherwise (other than the consideration to the extent expressly specified herein), (iii) the fairness of any portion or aspect of the Going Private Transactions to the holders of any class of securities, creditors or other constituencies of the Company, Purchaser, Parent, or to any other party, except if and only to the extent expressly set forth in the last sentence of Houlihan Lokey’s opinion, (iv) the relative merits of the Going Private Transactions as compared to any alternative business strategies or transactions that might be available for the Company, Purchaser, Parent or any other party, (v) the fairness of any portion or aspect of the Going Private Transactions to any one class or group of the Company’s, Purchaser’s, Parent’s or any other party’s security holders or other constituents vis-à-vis any other class or group of the Company’s, Purchaser’s, Parent’s or such other party’s security holders or other constituents (including, without limitation, the allocation of any consideration amongst or within such classes or groups of security holders or other constituents), (vi) whether or not the Company, Purchaser, Parent, their respective security holders or any other party is receiving or paying reasonably equivalent value in the Going Private Transactions, (vii) the solvency, creditworthiness or fair value of the Company, Purchaser or any other participant in the Going Private Transactions, or any of their respective assets, under any applicable laws relating to bankruptcy, insolvency, fraudulent conveyance or similar matters, or (viii) the fairness, financial or otherwise, of the amount, nature or any other aspect of any compensation to or consideration payable to or received by any officers, directors or employees of any party to the Going Private Transactions, any class of such persons or any other party, relative to the consideration or otherwise. Furthermore, no opinion, counsel or interpretation was intended in matters that require legal, regulatory, accounting, insurance, tax or other similar professional advice. Houlihan Lokey assumed that such opinions, counsel or interpretations were or would be obtained from the appropriate professional sources. Furthermore, Houlihan Lokey relied, with the consent of the Independent Board Committee, on the assessments by the Independent Board Committee, the Board, the Company, and their respective advisors, as to all legal, regulatory, accounting, insurance, tax and other similar matters with respect to the Company and the Going Private Transactions or otherwise.

 

In performing its analyses, Houlihan Lokey considered general business, economic, industry and market conditions, financial and otherwise, and other matters as they existed on, and could be evaluated as of, the date of its opinion. No company, transaction or business used in Houlihan Lokey’s analyses for comparative purposes is identical to the Company or the Going Private Transactions and an evaluation of the results of those analyses is not entirely

mathematical. The estimates contained in the Management Projections prepared by the management of the Company and the implied reference range values indicated by Houlihan Lokey’s analyses are not necessarily indicative of actual values or predictive of future results or values, which may be significantly more or less favorable than those suggested by the analyses. In addition, any analyses relating to the value of assets, businesses or securities do not purport to be appraisals or to reflect the prices at which businesses or securities actually may be sold, which may depend on a variety of factors, many of which are beyond the control of the Company. Much of the information used in, and accordingly the results of, Houlihan Lokey’s analyses are inherently subject to substantial uncertainty.

 

Houlihan Lokey’s opinion was only one of many factors considered by the Independent Board Committee in evaluating the Going Private Transactions. Neither Houlihan Lokey’s opinion nor its analyses were determinative of consideration of the Going Private Transactions or of the views of the Independent Board Committee with respect to the Going Private Transactions or the consideration of the Going Private Transactions. Under the terms of its engagement by the Company, neither Houlihan Lokey’s opinion nor any other advice or services rendered by it in connection with the Going Private Transactions or otherwise, should be construed as creating, and Houlihan Lokey should not be deemed to have, any fiduciary duty to, or agency relationships with, the Independent Board Committee, the Board, the Company, Purchaser, any security holder or creditor of the Company, Purchaser or any other person, regardless of any prior or ongoing advice or relationships. The type and amount of consideration payable in the Going Private Transactions were determined through negotiation between the Independent Board Committee and Purchaser.

 

In preparing its opinion to the Independent Board Committee, Houlihan Lokey performed a variety of analyses. The summary of Houlihan Lokey’s analyses is not a complete description of the analyses underlying Houlihan Lokey’s opinion. The preparation of such an opinion is a complex process involving various quantitative and qualitative judgments and determinations with respect to the financial, comparative and other analytical methods employed and the adaptation and application of these methods to the unique facts and circumstances presented. As a consequence, neither Houlihan Lokey’s opinion nor its underlying analyses are readily susceptible to summary description. Houlihan Lokey arrived at its opinion based on the results of all analyses undertaken by it and assessed as a whole and did not draw, in isolation, conclusions from or with regard to any individual analysis, methodology or factor. While the results of each analysis were taken into account in reaching Houlihan Lokey’s overall conclusion with respect to fairness, Houlihan Lokey did not make separate or quantifiable judgments regarding individual analyses. Accordingly, Houlihan Lokey believes that its analyses and the following summary must be considered as a whole and that selecting portions of its analyses, methodologies and factors, without considering all analyses, methodologies and factors, could create a misleading or incomplete view of the processes underlying Houlihan Lokey’s analyses and opinion.

 

The following is a summary of the material financial analyses performed by Houlihan Lokey in connection with the preparation of its opinion and reviewed with the Independent Board Committee on December 22, 2020. The order of the analyses does not represent relative importance or weight given to those analyses by Houlihan Lokey.

 

For purposes of its analyses, Houlihan Lokey reviewed a number of financial metrics, including:

The financial data reviewed included:

Houlihan Lokey was engaged by the Independent Board Committee to act as its financial advisor in connection with the Proposed Transaction and provide financial advisory services to the Independent Board Committee, including an opinion to the Independent Board Committee as to the fairness, from a financial point of view, of the consideration of $1.70 per Share or $2.55 per ADS to be received by the Unaffiliated Security Holders in the Going Private Transactions pursuant to the Offer to Purchase, as of the date of such opinion. The Independent Board Committee selected Houlihan Lokey to act as its financial advisor based on Houlihan Lokey’s qualifications, expertise and reputation, and its knowledge of the Company’s business and affairs. Houlihan Lokey is regularly engaged to provide financial advisory services in connection with mergers and acquisitions, financings, and financial restructurings. Pursuant to its engagement by the Independent Board Committee, Houlihan Lokey is entitled to a fixed fee of $650,000, payable as follows: (a) upon the execution of the engagement letter, $200,000; and upon the earlier of the execution by the Company of definitive legally binding documentation with respect to a transaction or Houlihan Lokey’s delivery of its opinion, US$400,000, and (c) upon closing of the Going Private Transactions, US$50,000. No portion of the fee is contingent upon any conclusions set forth in Houlihan Lokey’s opinion and, other than the US$50,000 payable upon closing of a transaction, no portion of the fee is contingent upon the consummation of the Going Private Transactions. The Company has also agreed to reimburse Houlihan Lokey for certain expenses and to indemnify Houlihan Lokey, its affiliates, and certain related parties against certain liabilities and expenses, including certain liabilities under the federal securities laws arising out of or related to Houlihan Lokey’s engagement.

 

In the ordinary course of business, certain of Houlihan Lokey’s employees and affiliates, as well as investment funds in which they may have financial interests or with which they may co-invest, may acquire, hold or sell, long or short positions, or trade, in debt, equity, and other securities and financial instruments (including loans and other obligations) of, or investments in, the Company, Purchaser, or any other party that may be involved in the Going Private Transactions and their respective affiliates or security holders or any currency or commodity that may be involved in the Going Private Transactions.

Neither Houlihan Lokey nor any of its affiliates has in the past two years provided or is currently providing any investment banking, financial advisory and/or other financial or consulting services to the Company, Purchaser, and their respective affiliates. Houlihan Lokey and certain of its affiliates may provide investment banking, financial advisory and/or other financial or consulting services to the Company, Parent, Purchaser, other participants in the Going Private Transactions or certain of their respective affiliates or security holders in the future, for which Houlihan Lokey and its affiliates may receive compensation. In addition, Houlihan Lokey and certain of its affiliates and certain of Houlihan Lokey’s and their respective employees may have committed to invest in private equity or other investment funds managed or advised by the Company, Parent, Purchaser, other participants in the Going Private Transactions or certain of their respective affiliates or security holders, and in portfolio companies of such funds, and may have co-invested with the Company, Parent, Purchaser, other participants in the Going Private Transactions or certain of their respective affiliates or security holders, and may do so in the future. Furthermore, in connection with bankruptcies, restructurings, distressed situations and similar matters, Houlihan Lokey and certain of its affiliates may have in the past acted, may currently be acting and may in the future act as financial advisor to debtors, creditors, equity holders, trustees, agents and other interested parties (including, without limitation, formal and informal committees or groups of creditors) that may have included or represented and may include or represent, directly or indirectly, or may be or have been adverse to, the Company, Purchaser, other participants in the Going Private Transactions or certain of their respective affiliates or security holders, for which advice and services Houlihan Lokey and its affiliates have received and may receive compensation.

After reasonable inquiry, the Company has not been notified by any executive officer, director, affiliate or subsidiary of the Company of his/its respective plan as to whether to tender any Class A Ordinary Shares/ADSs held of record or beneficially owned by such person or entity in the Offer.

Under the terms of Houlihan Lokey’s engagement, the Independent Board Committee has agreed to cause the Company to pay Houlihan Lokey a fee, payable as follows: (a) upon the execution of the engagement letter, $200,000; (b) upon the earlier of the execution by the Company of definitive legally binding documentation with respect to a transaction or Houlihan Lokey’s delivery of its opinion, US$400,000, and (c) upon closing of the Going Private Transactions, US$50,000. No portion of the fee is contingent upon any conclusions set forth in the Houlihan Lokey’s Opinion and, other than the US$50,000 payable upon closing of the Going Private Transactions, no portion of the fee is contingent upon the consummation of the Going Private Transactions. In addition, and regardless of whether the Going Private Transactions are consummated, the Company shall, upon Houlihan Lokey’s request, reimburse Houlihan Lokey for its reasonable out-of-pocket expenses incurred from time to time in connection with its services hereunder, not to exceed US$40,000 without the Committee or the Company’s prior approval, which approval shall not be unreasonably withheld. Furthermore, the Independent Board Committee has agreed to cause the Company to indemnify Houlihan Lokey and each of its affiliates past present and future, to the fullest extent lawful, from and against any and all losses, claims, damages or liabilities, joint or several, arising out of or related to Houlihan Lokey’s engagement.

Additional information pertaining to the retention of Houlihan Lokey by the Company in Item 4 under the heading “Opinion of the Independent Board Committee’s Financial Advisor” is hereby incorporated by reference in this Item 5.

Neither Company nor any person acting on its behalf has or currently intends to employ, retain or compensate any person to make solicitations or recommendations to the shareholders of the Company on its behalf with respect to the Offer or related matters.

Other than transactions otherwise disclosed herein, no transactions with respect to Class A Ordinary Shares or ADSs have been effected by the Company or, to the Company’s knowledge after making reasonable inquiry, by any of its executive officers, directors, affiliates, subsidiaries or any pension, profit-sharing or similar plan of the Company or affiliate during the 60 days prior to the date of this Schedule 14D-9.

 

Except as indicated in this Schedule 14D-9 (including the exhibits to this Schedule 14D-9 or incorporated in this Schedule 14D-9 by reference), the Company is not currently undertaking or engaged in any negotiations in response to the Offer that relate to, or would result in, (a) a tender offer for or other acquisitions of the Company’s securities by the Company, any subsidiary of the Company or any other person, (b) any extraordinary transaction, such as a merger, reorganization or liquidation, involving the Company or any subsidiary of the Company, (c) any purchase, sale or transfer of a material amount of assets of the Company or any subsidiary of the Company, or (d) any material change in any present dividend rate or policy, indebtedness or capitalization of the Company.

Except as indicated in this Schedule 14D-9 (including the exhibits to this Schedule 14D-9 or incorporated in this Schedule 14D-9 by reference), there are no transactions, board resolutions, agreements in principle or signed contracts that were entered into in response to the Offer that relate to, or would result in, one or more of the matters referred to in the preceding paragraph.

The Company is not aware of any filings, approvals or other actions by or with any governmental authority or administrative or regulatory agency, other than with the SEC, that would be required as a result of Parent’s or Purchaser’s acquisition or ownership of the Class A Ordinary Shares. There can be no assurance that any governmental authority will not challenge the acquisition of the Class A Ordinary Shares on competition or other grounds and if a challenge is made, the results cannot be predicted.

Because Parent and Purchaser are affiliates of the Company, the Going Private Transactions constitute a “going private” transaction under Rule 13e-3 under the Exchange Act. Rule 13e-3 requires, among other things, that certain information concerning the Company and certain information relating to the fairness of the Going Private Transactions and the consideration offered to the Company’s shareholders in the Offer and the Going Private Transactions be filed with the SEC and disclosed to the shareholders prior to consummation of the Offer and the Going Private Transactions. Such information has been provided in this Schedule 14D-9, the Schedule TO filed by Purchaser and Parent, and the Rule 13e-3 Transaction Statement to be filed by the Company, Parent and Purchaser (including the exhibits thereto).

The Company expects to, if necessary, call the General Meeting for the shareholders to approve, among others, the Share Consolidation. The Compulsory Acquisition does not require any approval by the Company’s shareholders at a General Meeting.

The Share Consolidation, on the other hand, needs approval from the shareholders of the Company at a General Meeting. Purchaser would control sufficient votes on its own to convene a General Meeting and to approve the Share Consolidation. The holders of Class A Ordinary Shares (including any Class A Ordinary Shares not tendered in the Offer and any Class A Shares delivered in a Surrender/Withdrawal, and after giving effect to any Depositary Sale) would not be entitled to appraisal rights.

Please refer to excerpt from Hong Kong Company Ordinance set forth in Annex C.

For additional information regarding the business and the financial results of the Company, please see the Form 20-F.

No lawsuits challenging the Going Private Transactions are currently pending; however, such suits may be filed in the future.

This Schedule 14D-9 and the materials incorporated by reference herein contain forward looking statements, including statements relating to the proposed acquisition of the Company by Parent and the expected benefits of the acquisition and other matters that are not historical facts. Statements in this communication that relate to future results and events are forward-looking statements based on the Company’s current plans and expectations and are subject to a number of risks and uncertainties that could cause such plans and expectations, including actual results, to differ materially from those described in these forward-looking statements. You should not place undue reliance on these statements. All statements other than statements of historical fact, including statements containing the words “estimates,” “believes,” “anticipates,” “plans,” “expects,” “will,” and similar expressions, are statements that could be deemed forward-looking statements. Risks, uncertainties and other factors include, but are not limited to: (a) the inability of Purchaser to complete the Offer due to the failure to satisfy the Offer Conditions; (b) the failure of the proposed Offer to close for any other reason; (c) the failure to complete the Subsequent Offering Period or any other transactions undertaken in the Second Step Options; (d) risks related to disruption of management’s attention from the Company’s ongoing business operations due to these transactions; (e) the outcome of any legal proceedings, regulatory proceedings or enforcement matters that may be instituted against the Company and others relating to the Going Private Transactions; (f) the risk that the pendency of the proposed Offer and Going Private Transactions disrupt current plans and operations and the potential difficulties in employee retention as a result of the pendency of the proposed Offer and the Going Private Transactions; (g) the effect of the announcement of the proposed Offer and the Going Private Transactions on the Company’s relationships with its customers, operating results and business generally; and (h) the amount of the costs, fees, expenses and charges related to the Going Private Transactions. You should consider these factors carefully in evaluating the forward-looking statements. Many of these risks and uncertainties are beyond the Company’s control. No assurance can be given that actual results or events will not differ materially from those projected, estimated, assumed or anticipated in any such forward-looking statements. Important factors that could result in such differences, in addition to other factors noted with such forward-looking statements, are discussed in the Company’s Annual Report on Form 20–F for the fiscal year ended December 31, 2019, which was filed with the SEC on May 22, 2020, under the heading “Item 3D. Risk Factors,” and in any subsequently filed Current Reports on Form 6-K filed by the Company with the SEC. Inclusion of any information or statement in this Schedule 14D-9 does not necessarily imply that such information or statement is material. The Company disclaims any intent or obligation to update any forward-looking statements as a result of developments occurring after the date of this Schedule 14D-9 or otherwise, and such information included in this Schedule 14D-9 is based on information currently available and may not be reliable after this date.

The following Exhibits are filed herewith or incorporated herein by reference:

 

 

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct.

Dated: December 23, 2020

 December 22, 2020

The Independent Committee of the Board of Directors of Wanda Sports Group Company Limited

9/F, Tower B, Wanda Plaza

93 Jianguo Road, Chaoyang District

100022, Beijing

People's Republic of China

Dear Members of the Independent Committee:

all of the covenants and agreements required to be performed by such party, (c) all conditions to the consummation of the Transaction will be satisfied without waiver thereof, and (d) the Transaction will be consummated in a timely manner in accordance with the terms described in the Offer to Purchase and such other related documents and instruments, without any amendments or modifications thereto. We have relied upon and assumed, without independent verification, that (i) the Transaction will be consummated in a manner that complies in all respects with all applicable foreign, federal and state statutes, rules and regulations, and (ii) all governmental, regulatory, and other consents and approvals necessary for the consummation of the Transaction will be obtained and that no delay, limitations, restrictions or conditions will be imposed or amendments, modifications or waivers made that would result in the disposition of any assets of the Company or the Purchaser, or otherwise have an effect on the Transaction, or the Company that would be material to our analyses or this Opinion. In addition, we have relied upon and assumed, without independent verification, that the final Offer to Purchase as filed with the Securities and Exchange Commission will not differ in any material respect from the draft of the Offer to Purchase identified above.

participants in the Transaction or certain of their respective affiliates or security holders, for which advice and services Houlihan Lokey and its affiliates have received and may receive compensation. 

Very truly yours,